Every SEC Form 3/4/5 on record for this filer (CIK 1287233) — 5 issuers, 15 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| PTGX | Protagonist Therapeutics, Inc | Director | 2016-08-10 → 2026-03-27 | 19 | −$2M |
| MTEM | Molecular Templates, Inc. | Director | 2017-10-11 → 2024-09-30 | 8 | — |
| PDLI | PDL BIOPHARMA, INC. | Director · lapsed | 2016-06-03 → 2019-06-24 | 4 | — |
| CBIO | CRESCENT BIOPHARMA, INC. | Director · lapsed | 2015-08-20 → 2018-01-18 | 7 | — |
| THLD | THRESHOLD PHARMACEUTICALS INC | Chief Executive Officer · Director · lapsed | 2016-03-15 → 2016-03-15 | 1 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| PTGX | 2026-03-26 | Sell | 24,000 | $105.00 | $3M | 60,845 |
| PTGX | 2020-03-12 | Buy | 12,000 | $6.70 | $80,400 | 15,310 |
2 of 5 issuers are covered and open a security page; the rest are on file here only.
